Kimberly-Clark buys Tylenol in US$48.7 billion consumer brands dealKimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about US$48.7 billion, creating a massive consumer health goods company. NDP urges action on pharmacare, dental care as health ministers meet in HalifaxHealth Minister Mark Holland is meeting with provincial and territorial health ministers in Halifax this week. Ontario signs $176 million deal with feds for rare disease treatments The three-year deal will fund the availability of five drugs and support improvements for early screening and diagnostic testing for rare diseases.
